Research Associate in nanoformulation for active transport across the tumour endothelium

Overview

In this postdoc, you will develop a novel nanomedicine targeting tumour blood vessels to enhance transport across the endothelial barrier, enabling better delivery to cancer cells. Based in the Najer Group (Materials) with the Bruna Group (ICR), you’ll work on a translational project addressing neuroblastoma. You will collaborate across groups, manage a CL2 lab, and contribute to science communication and patient engagement. This role offers exposure to multidisciplinary, high-impact cancer nanomedicine research with translational potential.

Pay / Benefits

• sector-leading salary and remuneration package
• 43 days off per year
• generous pension schemes
• development days (10)
• career support and progression opportunities
• diverse, inclusive and collaborative work culture

Responsibilities

• Formulate nanoparticles
• Characterise the final nanomedicine
• Study cell uptake and endothelium transport using trans-well setups
• Analyze data and present at workshops/conferences
• Collaborate with researchers across groups
• Contribute to patient engagement activities
• Manage a CL2 laboratory

Key requirements

• PhD in a related discipline (Materials Science/Nanomaterials/Biomaterials/Bioengineering/Microbiology or Cell Biology) or equivalent experience
• Experience in CL2 mammalian cell culture (essential)
• Experience in nanoparticle research in cells
• Experience with cellular analysis techniques (flow cytometry, confocal imaging)
• Knowledge of nanomedicine, drug delivery, anticancer therapies
• Excellent communication and organisational skills
• Ability to work independently and collaboratively in an international environment

• Kommunication and presentation
• Organisational skills
• Independent work ethic
• Nanoparticle formulation and characterization
• Cell culture in CL2/CL3 settings (desirable)
• Flow cytometry

…